Mou KY - Search Results

1

Endotoxin-Free Outer Membrane Vesicles for Safe and Modular Anticancer Immunotherapy.

Chen MY, Cheng TW, Pan YC, Mou CY, Chiang YW, Lin WC, Hu CJ, Mou KY. Chen MY, et al. Among authors: mou ky. ACS Synth Biol. 2025 Jan 17;14(1):148-160. doi: 10.1021/acssynbio.4c00483. Epub 2025 Jan 6. ACS Synth Biol. 2025. PMID: 39763210 Free PMC article.

2

Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication.

Liu CH, Pan YC, Lim SK, Mou CY, Hu CJ, Mou KY. Liu CH, et al. Among authors: mou ky. Cell Rep Med. 2024 Nov 19;5(11):101793. doi: 10.1016/j.xcrm.2024.101793. Epub 2024 Oct 22. Cell Rep Med. 2024. PMID: 39442515 Free PMC article.

3

High-Affinity Superantigen-Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression.

Yu YA, Lien WJ, Lin WC, Pan YC, Huang SW, Mou CY, Hu CJ, Mou KY. Yu YA, et al. Among authors: mou ky. Adv Sci (Weinh). 2024 Sep;11(33):e2310204. doi: 10.1002/advs.202310204. Epub 2024 Jun 27. Adv Sci (Weinh). 2024. PMID: 38937984 Free PMC article.

4

Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy.

Huang SW, Lim SK, Yu YA, Pan YC, Lien WJ, Mou CY, Hu CJ, Mou KY. Huang SW, et al. Among authors: mou ky. Elife. 2024 May 15;12:RP90798. doi: 10.7554/eLife.90798. Elife. 2024. PMID: 38747577 Free PMC article.

5

Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy.

Lim SK, Lin WC, Huang SW, Pan YC, Hu CW, Mou CY, Hu CJ, Mou KY. Lim SK, et al. Among authors: mou ky. EMBO Mol Med. 2024 Feb;16(2):416-428. doi: 10.1038/s44321-023-00022-w. Epub 2024 Jan 15. EMBO Mol Med. 2024. PMID: 38225455 Free PMC article.

6

Improvement of Gene Delivery by Minimal Bacteriophage Particles.

Kao CY, Pan YC, Hsiao YH, Lim SK, Cheng TW, Huang SW, Wu SM, Sun CP, Tao MH, Mou KY. Kao CY, et al. Among authors: mou ky. ACS Nano. 2023 Aug 8;17(15):14532-14544. doi: 10.1021/acsnano.3c01295. Epub 2023 Jul 19. ACS Nano. 2023. PMID: 37466994

7

Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia.

Sahoo BK, Lin YC, Tu CF, Lin CC, Liao WJ, Li FA, Li LH, Mou KY, Roffler SR, Wang SP, Yeh CT, Yao CY, Hou HA, Chou WC, Tien HF, Yang RB. Sahoo BK, et al. Among authors: mou ky. Haematologica. 2023 May 1;108(5):1284-1299. doi: 10.3324/haematol.2022.281151. Haematologica. 2023. PMID: 36005562 Free PMC article.

8

Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy.

Hu CW, Chang YC, Liu CH, Yu YA, Mou KY. Hu CW, et al. Among authors: mou ky. Mol Ther. 2022 Jul 6;30(7):2522-2536. doi: 10.1016/j.ymthe.2022.04.008. Epub 2022 Apr 18. Mol Ther. 2022. PMID: 35440418 Free PMC article.

9

Fragment-Directed Random Mutagenesis by the Reverse Kunkel Method.

Lin WC, Tang HC, Wang HY, Kao CY, Chang YC, Li AH, Yang SB, Mou KY. Lin WC, et al. Among authors: mou ky. ACS Synth Biol. 2022 Apr 15;11(4):1658-1668. doi: 10.1021/acssynbio.2c00086. Epub 2022 Mar 24. ACS Synth Biol. 2022. PMID: 35324156

10

Homogeneity test of relative risk ratios for stratified bilateral data under different algorithms.

Mou KY, Ma CX, Li ZM. Mou KY, et al. J Appl Stat. 2021 Dec 24;50(5):1060-1077. doi: 10.1080/02664763.2021.2017412. eCollection 2023. J Appl Stat. 2021. PMID: 37009591 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters